魯泰A(000726.SZ):已交易股票產生的收益對當期淨利潤的影響額為8104.45萬元
格隆匯6月25日丨魯泰A(000726.SZ)公佈,為提高公司資產流動性及使用效率,優化公司資產結構,滿足公司經營發展的需求,公司決定於2025年3月起適時選擇合理的價位區間通過二級市場競價交易系統擇機出售公司所持有的榮昌生物股份。交易定價依據為參照市場價格定價,出售時間、成交價格、成交金額、交易對手等均不確定。公司截至2024年12月31日持有榮昌生物391.8265萬股,佔其總股本的比例為0.72%,公司持有該股權的賬面價值為1.18億元,佔公司最近一個會計年度經審計淨資產的1.25%。無需經公司董事會審議,不構成關聯交易,不構成重大資產重組,交易實施不存在重大法律障礙。截至2025年6月24日,經公司初步核算,已交易股票產生的收益對當期淨利潤的影響額為8104.45萬元(未經審計),佔公司最近一個會計年度經審計歸屬於上市公司股東淨利潤的10%以上,達到《深圳證券交易所股票上市規則》6.1.2條規定的披露標準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.